IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days) • Valacyclovir 1 g PO BID or • Famciclovir 500 mg PO BID or • Acyclovir 400 mg PO TID Treating Initial or Recurrent Genital Lesions (Duration: 5–10 Days) • Valacyclovir 1 g PO BID or • Famciclovir 500 mg PO BID or • Acyclovir 400 mg PO TID Treating Severe Mucocutaneous HSV Infections: • Initial therapy acyclovir 5 mg/kg IV q8h • After lesions begin to regress, change to oral therapy as above. • Continue treatment until lesions have completely healed. #HerpesSimplex #HSV #IDSA #Prevention #Treatment #management #opportunistic #infections #HIVAIDS #pharmacology
